201 related articles for article (PubMed ID: 30627620)
1. Erythema dyschromicum perstans: A case report and systematic review of histologic presentation and treatment.
Leung N; Oliveira M; Selim MA; McKinley-Grant L; Lesesky E
Int J Womens Dermatol; 2018 Dec; 4(4):216-222. PubMed ID: 30627620
[TBL] [Abstract][Full Text] [Related]
2. Erythema Dyschromicum Perstans: Response to Topical Tacrolimus.
Mahajan VK; Chauhan PS; Mehta KS; Sharma AL
Indian J Dermatol; 2015; 60(5):525. PubMed ID: 26538750
[TBL] [Abstract][Full Text] [Related]
3. A Delphi consensus on the nomenclature and diagnosis of lichen planus pigmentosus and related entities.
Sarkar R; Vinay K; Bishnoi A; Poojary S; Gupta M; Kumaran MS; Jain A; Gurumurthy C; Arora P; Kandhari R; Rathi S; Zawar V; Gupta V; Ravivarma VN; Rodrigues M; Parsad D
Indian J Dermatol Venereol Leprol; 2023; 89(1):41-46. PubMed ID: 35593293
[TBL] [Abstract][Full Text] [Related]
4. Erythema dyschromicum perstans and lichen planus.
Naidorf KF; Cohen SR
Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
[TBL] [Abstract][Full Text] [Related]
5. Literature Review of Treatment Outcomes for Lichen Planus Pigmentosus, Erythema Dyschromicum Perstans, and Ashy Dermatosis.
Wu A; Vaidya S
J Cutan Med Surg; 2018; 22(6):643-645. PubMed ID: 30322299
[No Abstract] [Full Text] [Related]
6. Erythema dyschromicum perstans in children: a report of 14 cases.
Torrelo A; Zaballos P; Colmenero I; Mediero IG; de Prada I; Zambrano A
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):422-6. PubMed ID: 15987286
[TBL] [Abstract][Full Text] [Related]
7. A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
Kumarasinghe SPW; Pandya A; Chandran V; Rodrigues M; Dlova NC; Kang HY; Ramam M; Dayrit JF; Goh BK; Parsad D
Int J Dermatol; 2019 Mar; 58(3):263-272. PubMed ID: 30176055
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series.
Diaz A; Gillihan R; Motaparthi K; Rees A
JAAD Case Rep; 2020 Mar; 6(3):207-213. PubMed ID: 32149180
[No Abstract] [Full Text] [Related]
9. Erythema Dyschromicum Perstans: Identical to Ashy Dermatosis or Not?
Numata T; Harada K; Tsuboi R; Mitsuhashi Y
Case Rep Dermatol; 2015; 7(2):146-50. PubMed ID: 26351421
[TBL] [Abstract][Full Text] [Related]
10. Patch testing and histopathology in Thai patients with hyperpigmentation due to Erythema dyschromicum perstans, Lichen planus pigmentosus, and pigmented contact dermatitis.
Tienthavorn T; Tresukosol P; Sudtikoonaseth P
Asian Pac J Allergy Immunol; 2014 Jun; 32(2):185-92. PubMed ID: 25003734
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histological aspect of erythema dyschromicum perstans in Korea: A review of 68 cases.
Chang SE; Kim HW; Shin JM; Lee JH; Na JI; Roh MR; Lee JH; Lee GY; Ko JY
J Dermatol; 2015 Nov; 42(11):1053-7. PubMed ID: 26118942
[TBL] [Abstract][Full Text] [Related]
12. Lichen planus pigmentosus-like ashy dermatosis.
Cutrì FT; Ruocco E; Pettinato G; Ciancia G
Dermatol Reports; 2011 Oct; 3(3):e46. PubMed ID: 25386298
[TBL] [Abstract][Full Text] [Related]
13. Erythema dyschromicum perstans.
Tlougan BE; Gonzalez ME; Mandal RV; Kundu RV; Skopicki D
Dermatol Online J; 2010 Nov; 16(11):17. PubMed ID: 21163168
[TBL] [Abstract][Full Text] [Related]
14. A retrospective clinico-pathological study comparing lichen planus pigmentosus with ashy dermatosis.
Cheng HM; Chuah SY; Gan EY; Jhingan A; Thng STG
Australas J Dermatol; 2018 Nov; 59(4):322-327. PubMed ID: 29635779
[TBL] [Abstract][Full Text] [Related]
15. Successful Management of Erythema Dyschromicum Perstans Following Topical Ruxolitinib Therapy.
Srinivasan D; Gottlieb A
J Drugs Dermatol; 2023 Mar; 22(3):297-299. PubMed ID: 36877872
[TBL] [Abstract][Full Text] [Related]
16. Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment.
Wolfshohl JA; Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):60-62. PubMed ID: 27552666
[TBL] [Abstract][Full Text] [Related]
17. What's new in objective assessment and treatment of facial hyperpigmentation?
Molinar VE; Taylor SC; Pandya AG
Dermatol Clin; 2014 Apr; 32(2):123-35. PubMed ID: 24679999
[TBL] [Abstract][Full Text] [Related]
18. Erythema dyschromicum perstans: report of a new case and critical review of the literature.
Combemale P; Faisant M; Guennoc B; Dupin M; Heyraud JD
J Dermatol; 1998 Nov; 25(11):747-53. PubMed ID: 9863289
[TBL] [Abstract][Full Text] [Related]
19. Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)-Like Pigmentation in a Metastatic Breast Cancer Patient.
Mariano M; Donati P; Cameli N; Pigliacelli F; Morrone A; Cristaudo A
J Breast Cancer; 2021 Feb; 24(1):117-121. PubMed ID: 33634626
[TBL] [Abstract][Full Text] [Related]
20. Acquired Dermal Macular Hyperpigmentation Mimicking Dowling Degos Disease: A Case Report.
Ahmed WA; Badirah SB; Abdulwahab RA; Al Hawsawi K
Cureus; 2022 Aug; 14(8):e28150. PubMed ID: 36148207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
